Form 4: Disc Medicine Director Kevin Bitterman Sells 26,157 Shares

Director Kevin Bitterman sold 26,157 shares of Disc Medicine, Inc. at a weighted average price of $73.50 on March 5, 2024.

Summary

• On March 5, 2024, Kevin Bitterman, a director of Disc Medicine, Inc. (IRON), sold 26,157 shares of common stock at a weighted average price of $73.50.
• The sales occurred in multiple transactions with prices ranging from $73.00 to $73.80.
• Following the transaction, Bitterman directly owns no shares but indirectly owns 677,503 shares through Atlas Venture Opportunity Fund I, LP, 198,326 shares through Atlas Venture Opportunity Fund II, LP, and 51,000 shares through Atlas Venture Fund XII, L.P.
• Bitterman disclaims beneficial ownership of these indirectly held shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of a stock sale. The impact depends on the size of the sale relative to the director's holdings and overall trading volume.

Negatives

• A director selling shares could be perceived negatively by investors.

Risks

• The sale of shares by a director could indicate a lack of confidence in the company's future performance, although this is not explicitly stated.

Industry Context

Form 4 filings are routine disclosures of stock transactions by company insiders and are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• Shareholders may react to the news of a director selling shares, potentially impacting the stock price.

Key Dates